Do high levels of myocardial stress and inflammation biomarkers predict major cardiovascular adverse events in MI survivors?
A multimarker risk stratification approach using inflammation and myocardial stress biomarkers significantly improves the prediction of major cardiovascular adverse events in patients following a myocardial infarction.
Aim: Although there are short- and long-term prognostic studies in patients with myocardial infarction (MI), the data that can be used to predict the clinical outcome following discharge is limited. Materials & methods: We analyzed creatinine kinase-MB and troponin related to myonecrosis, suppression of tumorigenicity 2 and NT-pro B-type natriuretic peptide related to myocardial stress, C-reactive protein and procalcitonin related to inflammation in 259 MI patients. Results: Being in the high group for myocardial stress (odds ratio OR: 3.45, 95% CI: 1.398–8.547, p = 0.004) and inflammation markers (OR: 4.30, 95% CI: 1.690–10.899, p = 0.001) predicted major cardiovascular adverse events while myonecrosis markers could not (OR: 1.70, 95% CI: 0.671–4.306, p = 0.263). Conclusion: Using multimarker risk stratification composed of inflammation and myocardial stress biomarkers improves the prediction of major cardiovascular adverse events in MI survivors.
Somuncu et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: